Dogwood Therapeutics, Inc. (DWTX)
Dogwood Therapeutics, Inc. (DWTX) Insider Trading
Directors, officers and holders of more than 10% of DWTX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 34 most recent of 34 transactions on file: 0 with code P, 0 with code S and 34 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Sealbond Ltd | Director | A Award | 4,098,360 | $1.22 | $4,999,999 |
| Jun 16, 2026 | Keefer David R | Director | A Award | 16,800 | Not measured | Not measured |
| Jun 16, 2026 | Thomas John C | Director | A Award | 16,800 | Not measured | Not measured |
| Jun 16, 2026 | Whitley Richard James | Director | A Award | 16,800 | Not measured | Not measured |
| Jun 16, 2026 | De La Rosa Abel | Director | A Award | 16,800 | Not measured | Not measured |
| Mar 5, 2026 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | A Award | 82,500 | Not measured | Not measured |
| Mar 5, 2026 | Walsh Angela | Chief Financial Officer | A Award | 82,500 | Not measured | Not measured |
| Mar 5, 2026 | Grosswald Ralph | SVP OF OPERATIONS | A Award | 82,500 | Not measured | Not measured |
| Mar 5, 2026 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A Award | 330,000 | Not measured | Not measured |
| Dec 4, 2025 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | A Award | 150,000 | Not measured | Not measured |
| Dec 4, 2025 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A Award | 460,000 | Not measured | Not measured |
| Dec 4, 2025 | Walsh Angela | Chief Financial Officer | A Award | 150,000 | Not measured | Not measured |
| Dec 4, 2025 | Grosswald Ralph | SVP OF OPERATIONS | A Award | 150,000 | Not measured | Not measured |
| Nov 21, 2025 | Sealbond Ltd | Director | C Conversion | 21,610,950 | Not measured | Not measured |
| Nov 21, 2025 | Sealbond Ltd | Director | C Conversion | 2,842,638 | Not measured | Not measured |
| Nov 21, 2025 | Sealbond Ltd | Director | C Conversion | 284 | Not measured | Not measured |
| Nov 21, 2025 | Sealbond Ltd | Director | C Conversion | 2,161 | Not measured | Not measured |
| Jun 27, 2025 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A Award | 40,000 | Not measured | Not measured |
| Jun 27, 2025 | Keefer David R | Director | A Award | 2,362 | Not measured | Not measured |
| Jun 27, 2025 | Thomas John C | Director | A Award | 2,362 | Not measured | Not measured |
| Jun 27, 2025 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | A Award | 12,075 | Not measured | Not measured |
| Jun 27, 2025 | Whitley Richard James | Director | A Award | 2,362 | Not measured | Not measured |
| Jun 27, 2025 | Grosswald Ralph | SVP OF OPERATIONS | A Award | 12,075 | Not measured | Not measured |
| Jun 27, 2025 | Walsh Angela | Chief Financial Officer | A Award | 12,075 | Not measured | Not measured |
| Jun 27, 2025 | De La Rosa Abel | Director | A Award | 2,362 | Not measured | Not measured |
| Jun 18, 2025 | Whitley Richard James | Director | A Award | 210 | Not measured | Not measured |
| Jun 18, 2025 | De La Rosa Abel | Director | A Award | 210 | Not measured | Not measured |
| Jun 18, 2025 | De La Rosa Abel | Director | A Award | 210 | Not measured | Not measured |
| Jun 18, 2025 | Thomas John C | Director | A Award | 210 | Not measured | Not measured |
| Jun 18, 2025 | Thomas John C | Director | A Award | 210 | Not measured | Not measured |
| Jun 18, 2025 | Keefer David R | Director | A Award | 210 | Not measured | Not measured |
| Jun 18, 2025 | Keefer David R | Director | A Award | 210 | Not measured | Not measured |
| Jun 18, 2025 | Whitley Richard James | Director | A Award | 210 | Not measured | Not measured |
| Mar 12, 2025 | CK Life Sciences Intl (Holdings) Inc | Director | A Award | 284 | $7.01 | $1,993 |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.